We have moved to new location, Please click on contact us  
Home  >  News
you can get e-magazine links on WhatsApp. Click here
Technology + Font Resize -

Pfizer launches ‘Pfizer PAP India’ app for Indian patients to fast track enrolment to its Patient Access Programmes

Our Bureau, Mumbai
Friday, December 16, 2022, 14:30 Hrs  [IST]

With an aim to broaden access to Pfizer's innovative drugs to patients, India's leading pharmaceutical organization Pfizer launched ‘Pfizer PAP India’—a mobile application designed to ease and fast track enrolment to Pfizer's Patient Access Programmes (PAP). At present, Pfizer runs over 10 programmes supporting patients with Pfizer treatments.
The mobile application, available on both iOS and Android platforms, is designed to support patients who would like to be a part of Pfizer's Patient Access Programme. Pfizer's PAP offers eligible patients therapy assistance, based on a valid prescription by the treating physician and the submission of other required documents by the patient.
“Patients are at the heart of what we do. Improving access to our medicines via PAPs and providing information and support services ecosystem to help patients follow through in their treatment journey is our goal. The Pfizer PAP India app offers them a one-stop solution to meet this goal at the touch of a button. Till date, Pfizer has touched thousands of patient lives across the country through ongoing Patient Support Programs and we are now focused on improving the patient experience in this phase of our journey,” said Satyen Amin, director- commercial channel and market access, Pfizer India.
Patients can enroll in the programme by uploading the required documents. The confirmation of enrolment into the programme however is subject to the patient's medical eligibility, and verification of required documents.
The key features of the app is that it helps quickly select PAP scheme options, enables hassle-free documentation, easy fast-track enrolment and enhanced security.
Last year, Pfizer launched its patient charter that defined how they interact and assist patients across the country. The charter focuses on making patient insights integral to their operational strategy, delivering easier and faster access to innovative therapies, and partnering with patient groups to support them. The company has launched multiple programmes under this initiative over the last few months.
Speaking about the launch, Dr Rahul Bhargava, director and HOD - Department of Haematology and BMT Fortis hospital Gurgaon said, "We believe that access to medicines and medication adherence determines treatment effectiveness. These are some of the most useful interventions for improving health outcomes. However, this is possible only through regular patient monitoring and access to innovative medicines. Through the PAP app, patients can now seamlessly navigate their health journey on a single platform where they are enrolled. We are certain that this endeavour will benefit the healthcare ecosystem as well as the patients.”
PAP is executed by Tata 1 MG (MediAngels by Tata 1MG) on behalf of Pfizer India. “For us at Tata 1 MG, Cancer Care is not just about providing services to patients but more importantly helping them navigate the journey better, with compassion and care. We are proud of our association with Pfizer which has gone a step further with the launch of Pfizer PAP India mobile application. This app shall further enable patients to ease their access to medication and services through a self-serve platform. Now, patients will be able to avail all the applicable services directly and seamlessly by using the mobile application. Congratulations to the Pfizer and 1 MG teams for working collaboratively and continuing to innovate and enhance patient experience. This is yet another step closer to creating a better cancer journey for patients who need utmost care,” said Prashant Tandon, co-founder & CEO, Tata 1 MG.


* Name :     
* Email :    
  Website :  
India Lab Expo
Copyright © 2016 Saffron Media Pvt. Ltd |